MCK

768.06

1.65% 12.46

Vorhandelsmarkt: 766.34 -1.72 -0.22%

Mckesson Corp (MCK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$755.60

Offen:

$757

24-Stunden-Volumen:

1.06M

Relative Volume:

1.00

Marktkapitalisierung:

$89.92B

Einnahmen:

$403.43B

Nettoeinkommen (Verlust:

$5.10B

KGV:

19.97

EPS:

38.4657

Netto-Cashflow:

$5.41B

1W Leistung:

+0.20%

1M Leistung:

+4.52%

6M Leistung:

-6.37%

1J Leistung:

+5.54%

1-Tages-Spanne:

$747.65

$772.51

1-Wochen-Bereich:

$744.58

$784.14

52-Wochen-Spanne:

$637.00

$999.00

Mckesson Corp Stock (MCK) Company Profile

Firmenname

Mckesson Corp

Sektor

Healthcare (1092)

Branche

Medical Distribution (11)

Telefon

972-446-4800

Adresse

6555 STATE HIGHWAY 161, IRVING, TX

Mitarbeiter

43,000

Twitter

@McKesson

Nächster Verdiensttermin

2026-08-05

Neueste SEC-Einreichungen

MCK's Discussions on Twitter

Compare MCK vs COR, CAH, HSIC, AHG

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MCK Mckesson Corp	768.06	88.46B	403.43B	5.10B	5.41B	38.47
COR Cencora Inc	288.42	55.06B	328.68B	2.55B	1.56B	13.03
CAH Cardinal Health Inc	237.72	55.64B	250.74B	1.55B	4.39B	6.5398
HSIC Henry Schein Inc	84.52	9.51B	13.38B	418.00M	391.00M	3.3112
AHG Akso Health Group Adr	1.51	1.28B	14.85M	-136.07M	7.25M	-0.4726

Mckesson Corp Stock (MCK) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-09	Eingeleitet	Barclays	Overweight
2024-12-04	Fortgesetzt	Mizuho	Neutral
2024-11-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2024-09-24	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-09-05	Bestätigt	Leerink Partners	Outperform
2024-08-08	Bestätigt	Mizuho	Neutral
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2024-01-03	Eingeleitet	Barclays	Overweight
2023-12-14	Eingeleitet	Wells Fargo	Equal Weight
2023-03-31	Eingeleitet	Citigroup	Buy
2022-08-22	Fortgesetzt	Morgan Stanley	Overweight
2022-07-06	Herabstufung	Argus	Buy → Hold
2022-06-07	Hochstufung	Deutsche Bank	Hold → Buy
2022-04-01	Fortgesetzt	Credit Suisse	Outperform
2022-02-04	Herabstufung	Deutsche Bank	Buy → Hold
2022-01-07	Hochstufung	Credit Suisse	Neutral → Outperform
2021-11-02	Bestätigt	Barclays	Overweight
2021-11-02	Bestätigt	BofA Securities	Buy
2021-11-02	Bestätigt	Evercore ISI	Outperform
2021-11-02	Bestätigt	Jefferies	Buy
2021-03-30	Hochstufung	Argus	Hold → Buy
2020-11-02	Hochstufung	Barclays	Equal Weight → Overweight
2020-08-04	Hochstufung	Deutsche Bank	Hold → Buy
2020-05-22	Hochstufung	Wolfe Research	Peer Perform → Outperform
2020-05-15	Hochstufung	UBS	Neutral → Buy
2020-04-23	Fortgesetzt	Credit Suisse	Neutral
2020-03-18	Hochstufung	Goldman	Neutral → Buy
2020-03-13	Hochstufung	Guggenheim	Neutral → Buy
2020-02-07	Hochstufung	Robert W. Baird	Neutral → Outperform
2020-01-10	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2019-09-12	Eingeleitet	Deutsche Bank	Hold
2019-08-05	Herabstufung	Wolfe Research	Outperform → Peer Perform
2019-07-22	Eingeleitet	Guggenheim	Neutral
2019-01-17	Eingeleitet	UBS	Neutral
2018-10-26	Bestätigt	Barclays	Equal Weight
2018-07-20	Herabstufung	Robert W. Baird	Outperform → Neutral
2018-05-29	Bestätigt	Leerink Partners	Mkt Perform
2018-03-08	Eingeleitet	Barclays	Equal Weight
2018-02-27	Fortgesetzt	BofA/Merrill	Buy
2018-02-02	Bestätigt	Mizuho	Neutral
2018-01-24	Hochstufung	Jefferies	Hold → Buy

Alle ansehen

Mckesson Corp Aktie (MCK) Neueste Nachrichten

Jul 01, 2026

McKesson (MCK) Spotlights AI-Powered Tools for Independent Pharmacies at Its Annual ideaShare Conference - Insider Monkey

Jul 01, 2026

McKesson exec to retire in another C-suite change for pharma giant - The Business Journals

Jul 01, 2026

McKesson Corporation (MCK) Announces Executive Leadership Transi - GuruFocus

Jul 01, 2026

McKesson (NYSE: MCK) EVP Rodgers to retire, Srinivasan to lead strategy - Stock Titan

Jul 01, 2026

McKesson Patient Room Hygiene Kit from McKessonSmall accessory, big impact on hospital safety - AD HOC NEWS

Jul 01, 2026

The McKesson Brand Insulin SyringeSmall detail that shapes diabetes care - AD HOC NEWS

Jul 01, 2026

Jun 30, 2026

Will Defensive Index Additions and TempraMed Deal Change McKesson's (MCK) Risk Perception Narrative - Yahoo Finance

Jun 30, 2026

McKesson OneTrack Inventory from McKesson Corp.hospital buyers get tighter control - AD HOC NEWS

Jun 30, 2026

TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels - Yahoo Finance

Jun 30, 2026

Jun 29, 2026

McKesson (MCK) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance

Jun 29, 2026

McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jun 29, 2026

Is McKesson Corporation (MCK) A Good Stock To Buy Now? - Yahoo Finance

Jun 29, 2026

McKesson WoundCare Program from McKesson Corp.homecare kits streamline chronic wound treatment - AD HOC NEWS

Jun 29, 2026

3 Reasons We Love McKesson (MCK) - Yahoo Finance

Jun 29, 2026

Jun 26, 2026

Oral Argument: McLaughlin Chiropractic Assoc. V. McKesson Corp. | Case No. 23-1226 | Date Argued:... Empoli Monza (T0IRB9JBTR) - Fathom Journal

Jun 26, 2026

McKesson Corporation (MCK) - Investing.com Nigeria

Jun 26, 2026

TCW Concentrated Large Cap Growth Fund's McKesson Corp(MCK) Holding History - GuruFocus

Jun 26, 2026

Jun 24, 2026

McKesson to build $179 million automated DC in Oklahoma - DC Velocity

Jun 24, 2026

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Jun 24, 2026

McKesson sets Aug. 5 earnings call after market close - Stock Titan

Jun 24, 2026

McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date - The Joplin Globe

Jun 24, 2026

McKesson - Forbes

Jun 24, 2026